Welcome to our dedicated page for Cre8 Enterprise, Ltd. SEC filings (Ticker: CRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cre8 Enterprise, Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cre8 Enterprise, Ltd.'s regulatory disclosures and financial reporting.
Cre8 Enterprise Limited pre-IPO shareholders Mr. Seng Jin LEE and Cre8 Investments Limited filed a Schedule 13D disclosing beneficial ownership of 6,435,000 Class A ordinary shares and 4,500,000 Class B ordinary shares. Based on the issuer's prospectus and Form 6-K, these holdings represent approximately 32.72% of Class A and 87.93% of the aggregate voting power of issued Class A and Class B shares because each Class B share carries 20 votes versus one vote for each Class A share. An Acting-in-Concert Agreement designates Mr. Seng Jin LEE as sole representative with exclusive authority to direct the vote of the parties to that agreement. The shares were acquired through the issuer's group reorganization in connection with its incorporation and IPO preparation.
Cre8 Enterprise Limited (NASDAQ: CRE) disclosed that American Trust Investment Services, acting as lead underwriter, fully exercised the IPO over-allotment option on 28 Jul 2025. The option covered 217,500 Class A ordinary shares at the original offering price of US$4.00 per share; closing occurred on 30 Jul 2025.
The exercise supplied an extra US$0.87 million in gross proceeds, bringing total IPO gross proceeds to US$6.67 million before underwriting discounts and related expenses. A press release detailing the transaction is included as Exhibit 99.1.
The full greenshoe take-up indicates healthy aftermarket demand and adds incremental liquidity for corporate uses, albeit with a slight increase in share count and dilution to existing holders.
FAQ
What is the current stock price of Cre8 Enterprise, Ltd. (CRE)?
What is the market cap of Cre8 Enterprise, Ltd. (CRE)?
